Interventions to prevent the initiation of injection drug use: A systematic review

Drug and Alcohol Dependence

Volumn 133, Issue 2, 2013, Pages 669-676

  Werb, Dan ^a   Buxton, Jane ^b   Shoveller, Jeannie ^c   Richardson, Chris ^c   Rowell, Greg ^d   Wood, Evan ^a  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Clinical Policy Office   (Canada)

Author keywords

Initiation; Injecting; Interventions; Prevention; Systematic review

Indexed keywords

ADDICTION; ARTICLE; BEHAVIOR MODIFICATION; CLINICAL EFFECTIVENESS; DATA BASE; DRUG ABUSE; DRUG LEGISLATION; HUMAN; INJECTION DRUG USE; INTERNET; LONGITUDINAL STUDY; OBSERVATIONAL STUDY; PEER REVIEW; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL MARKETING; SYSTEMATIC REVIEW;

INITIATION; INJECTING; INTERVENTIONS; PREVENTION; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; BODY MODIFICATION, NON-THERAPEUTIC; FEMALE; GUIDELINES AS TOPIC; HIV INFECTIONS; HUMANS; LAW ENFORCEMENT; LEGISLATION, DRUG; MALE; MIDDLE AGED; PUBLICATION BIAS; SOCIAL MARKETING; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES; YOUNG ADULT;

EID: 84887023753     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.08.017     Document Type: Article

References (58)

1. Beyrer C., Malinowska-Sempruch K., Kamarulzaman A., Kazatchkine M., Sidibe M., Strathdee S.A. Time to act: a call for comprehensive responses to HIV in people who use drugs. Lancet 2010, 376:551-563.
2. Binswanger I.A., Kral A.H., Bluthenthal R.N., Rybold D.J., Edlin B.R. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin. Infect. Dis. 2000, 30:579.
3. Ciccarone D. Heroin in brown, black and white: structural factors and medical consequences in the US heroin market. Int. J. Drug Policy 2009, 20:277-282.
4. Cooper H.L.F., Wypij D., Krieger N. Police drug crackdowns and hospitalisation rates for illicit-injection-related infections in New York City. Int. J. Drug Policy 2005, 16:150.
5. Crofts N., Louie R., Rosenthal D., Jolley D. The first hit: circumstances surrounding initiation into injecting. Addiction 1996, 91:1187-1196.
6. Day C., Degenhardt L., Hall W. Changes in the initiation of heroin use after a reduction in heroin supply. Drug Alcohol Rev. 2006, 25:307-313.
7. Degenhardt L., Day C., Hall W. The Causes, Course and Consequences of the Heroin Shortage in Australia 2004, National Drug and Alcohol Centre, Sydney.
8. Des Jarlais C.D., Casriel C., Friedman S.R., Rosenblum A. AIDS and the transition to illicit drug injection: results of a randomized trial prevention program. Br. J. Addict. 1992, 87:6.
9. Des Jarlais D.C., Diaz T., Perlis T., Vlahov D., Maslow C., Latka M., Rockwell R., Edwards V., Friedman S.R., Monterroso E. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am. J. Epidemiol. 2003, 157:467-471.
10. Doherty M.C., Monterroso E. Gender differences in the initiation of injection drug use among young adults. J. Urban Health 2000, 77:396-414.
11. Downs S.H., Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J. Epidemiol. Community Health 1998, 52:377-384.
12. EHRN Achievements of Prevention of Injection Among Non-injectors (Break the Cycle) in Albania 2011, http://www.harm-reduction.org/news/2103-achievements-of-prevention-of-injection-among-non-injectors-break-the-cycle-in-albania.html. Accessed on 01.08.13.
13. Fast D., Small W., Krusi A., Wood E., Kerr T. 'I guess my own fancy screwed me over': transitions in drug use and the context of choice among young people entrenched in an open drug scene. BMC Public Health 2010, 10:10.
14. Fennema J.S.A., Ameijden E., Hoek A.V.D., Coutinho R.A. Young and recent-onset injecting drug users are at higher risk for HIV. Addiction 1997, 92:1457-1466.
15. Friedman S.R., Cooper H.L., Tempalski B., Keem B., Friedman R., Flom P.L., Des Jarlais D.C. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS 2006, 20:93.
16. Friedman S.R., Pouget E.R., Chatterjee S., Cleland C.M., Tempalski B., Brady J.E., Cooper H.L.F. Drug arrests and injection drug deterrence. Am. J. Public Health 2011, 101:344.
17. Garfein R.S., Doherty M.C., Monterroso E.R., Thomas D.L., Nelson K.E., Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1998, 18.
18. Garfein R.S., Vlahov D., Galai N., Doherty M.C., Nelson K.E. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am. J. Public Health 1996, 86:655.
19. Gossop M.M., Griffiths P., Powis B., Strang J. Severity of dependence and route of administration of heroin, cocaine and amphetamines. Addiction 1992, 87:1527-1536.
20. Gray R. Preventing IDU Initiation Among Drug-Curious Youth: An Attempt to Measurably Reduce IDU Initiation Among Youth in Central Asia 2008, 19th International Harm Reduction Association Conference, Barcelona, Spain.
21. Harocopos A., Goldsamt L.A., Kobrak P., Jost J.J., Clatts M.C. New injectors and the social context of injection initiation. Int. J. Drug Policy 2009, 20:317-323.
22. Hunt N., Stillwell G., Taylor C., Griffiths P. Evaluation of a brief intervention to prevent initiation into injecting. Drugs Educ. Prev. Policy 1998, 5:185-194.
23. Kelley M.S., Chitwood D.D. Effects of drug treatment for heroin sniffers: a protective factor against moving to injection?. Soc. Sci. Med. 2004, 58:2083.
24. Kermode M., Longleng V., Singh B.C., Bowen K., Rintoul A. Killing time with enjoyment: a qualitative study of initiation into injecting drug use in north-east India. Subst. Use Misuse 2009, 44:1070-1089.
25. Koram N., Liu H., Li J., Luo J., Nield J. Role of social network dimensions in the transition to injection drug use: actions speak louder than words. AIDS Behav. 2011, 1-10.
26. Li T.S., Tubiana R., Katlama C., Calvez V., Mohand H.A., Autran B. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998, 351:1682-1686.
27. Lloyd-Smith E., Kerr T., Hogg R.S., Li K., Montaner J.S., Wood E. Prevalence and correlates of abscesses among a cohort of injection drug users. Harm. Reduct. J. 2005, 2:24.
28. Mallen C., Peat G., Croft P. Quality assessment of observational studies is not commonplace in systematic reviews. J. Clin. Epidemiol. 2006, 59:765-769.
29. Mathers B.M., Degenhardt L., Phillips B., Wiessing L., Hickman M., Strathdee S.A., Wodak A., Panda S., Tyndall M., Toufik A., Mattick R.P. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008, 372:1733-1745.
30. McCambridge J. A case study of publication bias in an influential series of reviews of drug education. Drug Alcohol Rev. 2007, 26:463.
31. Miller C.L., Johnston C., Spittal P.M., Li K., Laliberte N., Montaner J.S., Schechter M.T. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology 2002, 36:737.
32. Miller C.L., Strathdee S.A., Kerr T., Li K., Wood E. Factors associated with early adolescent initiation into injection drug use: implications for intervention programs. J. Adolesc. Health 2006, 38:462-464.
33. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Br. Med. J. 2009, 339:b2535.
34. National Institutes of Health Medical Subject Headings 2013, http://www.nlm.nih.gov/mesh/. Accessed on 01.08.13.
35. Neaigus A., Friedman S.R., Curtis R., Des Jarlais D.C., Furst R.T., Jose B., Mota P., Stepherson B., Sufian M., Ward T., et al. The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. Soc. Sci. Med. 1994, 38:67.
36. Olivo S.A., Macedo L.G., Gadotti I.C., Fuentes J., Stanton T., Magee D.J. Scales to assess the quality of randomized controlled trials: a systematic review. Phys. Ther. 2008, 88:156-175.
37. Pearson H. A hard habit to break. Nature 2004, 430:2.
38. Piantadosi S., Byar D.P., Green S.B. The ecological fallacy. Am. J. Epidemiol. 1988, 127:893-904.
39. Rhodes T., Platt L., Maximova S., Koshkina E., Latishevskaya N., Hickman M., Renton A., Bobrova N., McDonald T., Parry J.V. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction 2006, 101:252-266.
40. Ritter A., Cameron J. A Systematic Review of Harm Reduction. Drug Policy Modeling Project Monograph Series 2005, Turning Point Alcohol and Drug Centre, Fitzroy.
41. Roy E., Denis V., Gutierrez N., Haley N., Morissette C., Boudreau J.F.Ã. Evaluation of a media campaign aimed at preventing initiation into drug injection among street youth. Drugs Educ. Prev. Policy 2007, 14:401-414.
42. Roy E., Haley N., Leclerc P., Cedras L., Blais L., Boivin J.F. Drug injection among street youths in Montreal: predictors of initiation. J. Urban Health 2003, 80:92.
43. Saunders J.B. Publication bias in addiction research. Drug Alcohol Rev. 2007, 26:3.
44. Seal K.H., Kral A.H., Gee L., Moore L.D., Bluthenthal R.N., Lorvick J., Edlin B.R. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999. Am. J. Public Health 2001, 91:1842-1846.
45. Shepard C.W., Finelli L., Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 2005, 5:558-567.
46. Stenbacka M. Initiation into intravenous drug abuse. Acta Psychiatr. Scand. 1990, 81:459-462.
47. Strang J., Des Jarlais D.C., Griffiths P., Gossop M. The study of transitions in the route of drug use: the route from one route to another. Br. J. Addict. 1992, 87:473-483.
48. Strang J., Griffiths P., Powis B., Abbey J., Gossop M. How constant is an individual's route of heroin administration? Data from treatment and non-treatment samples. Drug Alcohol Depend. 1997, 46:115-118.
49. Trenz R.C., Scherer M., Harrell P., Zur J., Sinha A., Latimer W. Early onset of drug and polysubstance use as predictors of injection drug use among adult drug users. Addict. Behav. 2012, 37:367-372.
50. UNAIDS AIDS Epidemic Update: November 2009. Joint United Nations Programme on HIV/AIDS, Geneva 2009.
51. UNODC HIV Prevention Among Young Injecting Drug Users 2004, United Nations Office on Drugs and Crime, Vienna.
52. Vlahov D., Fuller C.M., Ompad D.C., Galea S., Des Jarlais D.C. Updating the infection risk reduction hierarchy: preventing transition into injection. J. Urban Health 2004, 81:14.
53. Weatherburn D., Jones C., Freeman K., Makkai T. Supply control and harm reduction: lessons from the Australian heroin drought. Addiction 2003, 98:83.
54. Werb D., Kerr T., Fast D., Qi J., Montaner J.S.G., Wood E. Drug-related risks among street youth in two neighborhoods in a Canadian setting. Health Place 2010, 16:1061-1067.
55. Werner S.B., Passaro D., McGee J., Schechter R., Vugia D.J. Wound botulism in California, 1951-1998: recent epidemic in heroin injectors. Clin. Infect. Dis. 2000, 31:1018-1024.
56. Wolfe D., Malinowska-Sempruch K. Illicit Drug Policies and the Global HIV Epidemic: Effects of UN and National Government Approaches 2004, Open Society Institute, New York.
57. Wood E., Stoltz J.-A., Li K., Montaner J.S.G., Kerr T. Changes in Canadian heroin supply coinciding with the Australian heroin shortage. Addiction 2006, 101:689-695.
58. Young A.M., Havens J.R. Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis. Addiction 2012, 107:587-596.